Pier Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-81,036
Closed -$5.52M 126
2024
Q3
$5.52M Buy
+81,036
New +$4.57M 0.78% 72
2020
Q1
Sell
-4,818
Closed -$446K 112
2019
Q4
$446K Buy
4,818
+1,383
+40% +$122K 0.07% 102
2019
Q3
$310K Sell
3,435
-2,320
-40% -$264K 0.05% 102
2019
Q2
$679K Sell
5,755
-641
-10% -$64.6K 0.11% 98
2019
Q1
$554K Buy
6,396
+425
+7% +$36.2K 0.09% 95
2018
Q4
$377K Buy
+5,971
New +$410K 0.07% 104
2018
Q1
Sell
-73,449
Closed -$3.86M 115
2017
Q4
$3.86M Sell
73,449
-4,293
-6% -$229K 0.66% 89
2017
Q3
$3.66M Sell
77,742
-11,701
-13% -$471K 0.64% 89
2017
Q2
$3.16M Sell
89,443
-243,006
-73% -$7.5M 0.55% 93
2017
Q1
$7.85M Sell
332,449
-478
-0.1% -$9.47K 1.34% 5
2016
Q4
$4.45M Buy
332,927
+130,274
+64% +$2.1M 0.8% 85
2016
Q3
$3.76M Buy
+202,653
New +$3.57M 0.67% 89
2015
Q1
Sell
-238,665
Closed -$6.55M 111
2014
Q4
$6.55M Buy
+238,665
New +$5.81M 0.97% 63
2014
Q1
Sell
-571,504
Closed -$6.71M 148
2013
Q4
$6.71M Buy
+571,504
New +$6.56M 0.9% 68
2013
Q3
Sell
-636,481
Closed -$8.85M 145
2013
Q2
$8.85M Buy
+636,481
New +$6.91M 1.35% 15

Other funds holding EXAS

Pier Capital's EXAS Position: Q4 2024 in Review

Pier Capital sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 81,036 shares — an estimated $5.52M sold.

Pier Capital first reported a position in EXAS in Q2 2013 and held it in 15 quarters. The position peaked at $8.85M in Q2 2013. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Pier Capital reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Pier Capital sold 81,036 Exact Sciences shares in Q4 2024, an estimated $5.52M.
  • Pier Capital first reported a position in Exact Sciences in Q2 2013 and held it in 15 quarters.
  • Pier Capital's Exact Sciences position peaked at $8.85M in Q2 2013.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Pier Capital's 13F filing for Q4 2024, filed 11 Feb 2025.